Literature DB >> 21927960

Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture.

Alfred C F Rumondor1, Håkan Wikström, Bernard Van Eerdenbrugh, Lynne S Taylor.   

Abstract

Formulation of an amorphous solid dispersion (ASD) is one of the methods commonly considered to increase the bioavailability of a poorly water-soluble small-molecule active pharmaceutical ingredient (API). However, many factors have to be considered in designing an API-polymer system, including any potential changes to the physical stability of the API. In this study, the tendency of ASD systems containing a poorly water-soluble API and a polymer to undergo amorphous-amorphous phase separation was evaluated following exposure to moisture at increasing relative humidity. Infrared spectroscopy was used as the primary method to investigate the phase behavior of the systems. In general, it was observed that stronger drug-polymer interactions, low-ASD hygroscopicity, and a less hydrophobic API led to the formation of systems resistant to moisture-induced amorphous-amorphous phase separation. Orthogonal partial least squares analysis provided further insight into the systems, confirming the importance of the aforementioned properties. In order to design a more physically stable ASD that is resistant to moisture-induced amorphous-amorphous phase separation, it is important to consider the interplay between these properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927960      PMCID: PMC3225547          DOI: 10.1208/s12249-011-9686-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  22 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Physical stability studies of miscible amorphous solid dispersions.

Authors:  Igor Ivanisevic
Journal:  J Pharm Sci       Date:  2010-09       Impact factor: 3.534

3.  Release rates of ketoprofen from poloxamer gels in a membraneless diffusion cell.

Authors:  S C Chi; H W Jun
Journal:  J Pharm Sci       Date:  1991-03       Impact factor: 3.534

4.  Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?

Authors:  Feng Qian; Jun Huang; Qing Zhu; Raja Haddadin; John Gawel; Robert Garmise; Munir Hussain
Journal:  Int J Pharm       Date:  2010-05-24       Impact factor: 5.875

5.  A classification system to assess the crystallization tendency of organic molecules from undercooled melts.

Authors:  Jared A Baird; Bernard Van Eerdenbrugh; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2010-09       Impact factor: 3.534

6.  A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug.

Authors:  E Broman; C Khoo; L S Taylor
Journal:  Int J Pharm       Date:  2001-07-03       Impact factor: 5.875

7.  A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers.

Authors:  Xiaolin Charlie Tang; Michael J Pikal; Lynne S Taylor
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

8.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

9.  Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).

Authors:  Patrick J Marsac; Alfred C F Rumondor; David E Nivens; Umesh S Kestur; Lia Stanciu; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

10.  Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.

Authors:  Alfred C F Rumondor; Lynne S Taylor
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

View more
  15 in total

1.  Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.

Authors:  Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-09-27       Impact factor: 4.200

2.  In Vitro-In Vivo Relationship of Amorphous Insoluble API (Progesterone) in PLGA Microspheres.

Authors:  Chenguang Pu; Qiao Wang; Hongjuan Zhang; Jingxin Gou; Yuting Guo; Xinyi Tan; Bin Xie; Na Yin; Haibing He; Yu Zhang; Yanjiao Wang; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2017-09-25       Impact factor: 4.200

3.  Melt Extrusion of High-Dose Co-Amorphous Drug-Drug Combinations : Theme: Formulation and Manufacturing of Solid Dosage Forms Guest Editors: Tony Zhou and Tonglei Li.

Authors:  Lærke Arnfast; Md Kamruzzaman; Korbinian Löbmann; Johanna Aho; Stefania Baldursdottir; Thomas Rades; Jukka Rantanen
Journal:  Pharm Res       Date:  2017-09-19       Impact factor: 4.200

4.  Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.

Authors:  Derek S Frank; Adam J Matzger
Journal:  Mol Pharm       Date:  2018-06-20       Impact factor: 4.939

5.  Screening methodologies for the development of spray-dried amorphous solid dispersions.

Authors:  Íris Duarte; José Luís Santos; João F Pinto; Márcio Temtem
Journal:  Pharm Res       Date:  2014-08-19       Impact factor: 4.200

6.  The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range.

Authors:  Yiwei Tian; Kaijie Qian; Esther Jacobs; Esther Amstad; David S Jones; Lorenzo Stella; Gavin P Andrews
Journal:  Pharmaceutics       Date:  2019-08-19       Impact factor: 6.321

7.  Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.

Authors:  Anura S Indulkar; Xiaochun Lou; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2022-02-15       Impact factor: 4.200

8.  Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation.

Authors:  Sonal V Bhujbal; Vaibhav Pathak; Dmitry Y Zemlyanov; Lynne S Taylor; Qi Tony Zhou
Journal:  J Pharm Sci       Date:  2020-12-31       Impact factor: 3.534

Review 9.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

10.  Mutual Effects of Hydrogen Bonding and Polymer Hydrophobicity on Ibuprofen Crystal Inhibition in Solid Dispersions with Poly(N-vinyl pyrrolidone) and Poly(2-oxazolines).

Authors:  Xiaoning Shan; Maryam A Moghul; Adrian C Williams; Vitaliy V Khutoryanskiy
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.